Clinical and Pathologic Studies in Neuroendocrine Tumors

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00657332

Enrollment

Registered

2008-04-14

Start date

2007-07-31

Completion date

2008-06-17

Last updated

2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoid Tumor, Neuroendocrine Tumors

Brief summary

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies performed during your regular medical care (i.e. tissue leftover after your diagnosis has been made) and/or blood and urine samples. This study may lead to the development of special materials that could be used, in the future, to treat neuroendocrine tumors or to follow the response of neuroendocrine tumors to treatment

Interventions

PROCEDUREblood sample draw

PROCEDUREurine sample

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

- Patients are eligible if they have a histologically proven neuroendocrine tumor and are 18 years of age or older \- Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

None

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026